Atlas Trials

Jubilant Therapeutics India Limited

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jubilant Therapeutics India Limited

RecordFirmDate
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor (NCT07755397)Jubilant Therapeutics India Limited2024-08-26

Track Jubilant Therapeutics India Limited automatically

Every clearance here is in the API, with alerts when new ones post.